Prosensa: Results Confirms Positive Outcome Of Demand II Study, Which Met Primary Endpoint, With No Reported Major Safety Concerns - DJ

by Eddie Staley, Benzinga Editor
September 8, 2014 8:06 AM | 5 seconds read | Make a Comment
Loading...
Loading...
  • FDA Submission Planned Before End of Year and EMA Submission Shortly Thereafter
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Posted In: NewsFDA
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!